This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: The Innovative Genius of Maxime C. Soumeillant
Introduction
Maxime C. Soumeillant is a notable inventor based in Hamilton Square, NJ, specializing in pharmaceutical innovations. With a commendable portfolio of seven patents, his work focuses primarily on the development of therapies targeting critical health issues.
Latest Patents
Among his latest inventions are methods for the preparation of HIV attachment inhibitor piperazine prodrug compounds. These patents detail efficient methods for synthesizing this crucial compound, enhancing the prospects for effective HIV treatments.
Career Highlights
Maxime is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical firm. His contributions to the field have positioned him as an influential figure within the company, driving advancements in medical science.
Collaborations
Throughout his career, Maxime has collaborated with esteemed colleagues such as Martin D. Eastgate and Michael S. Bultman. These professional partnerships have fostered an environment of innovation, enabling the development of groundbreaking solutions in healthcare.
Conclusion
Maxime C. Soumeillant’s dedication to his craft and innovative spirit exemplifies the essence of modern inventors. His work continues to inspire advancements in the pharmaceutical industry, making significant strides in the fight against HIV and other diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile